To be noted, when CRC patients were stratified by early and advanced AJCC stages, our data showed that HLA-G levels were only related to the survival in CRC patients with early disease stage, and ILT-4 levels were significant for both CRC patients with early and advanced disease stages. This evidence concerns the gene LILRB2 and colorectal carcinoma.